on 19 Jan 2021
Last Applicant/ Owned by
SAWSTON CAMBRIDGESHIRE
REINO UNIOD
CB22 3HJ
Serial Number
88482082 filed on 20th Jun 2019
Registration Number
6248406 registered on 19th Jan 2021
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceuticals and pharmaceutical preparations for the treatment of diseases and conditions associated with ion channel activity; drug delivery agents in the form of liquid preparations for infusion or injection that facilitate the delivery of pharmaceutical preparations; antibodies for medical use, namely, ion channel blocking antibodies and antibodies derived from mini-protein toxins; pharmaceuRead More
Chemicals for use in industry and science, excluding nanomaterial-based chemicals; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
Pharmaceuticals and pharmaceutical preparations for the treatment of diseases and conditions associated with ion channel activity; drug delivery agents in the form of liquid preparations for infusion or injection that facilitate the delivery of pharmaceutical preparations; antibodies for medical use, namely, ion channel blocking antibodies and antibodies derived from mini-protein toxins; pharmaceuticals and pharmaceutical preparations incorporating antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, for the treatment of diseases and conditions associated with ion channel activity
Scientific and technological services, namely, scientific research, analysis and testing in the fields of pharmaceuticals, biochemicals, polypeptides, antibodies, ion channel blocking antibodies and antibodies derived from mini-protein toxins; drug discovery services and pharmaceutical drug development services; conducting or providing research and development services for others in the field of antibodies; scientific laboratory services relating to the production of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins
Medical services; medical services connected with the treatment of diseases through the use of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid
No 88482082
No Service Mark
No 0206.001-TM
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Jan 2021 | REGISTERED-PRINCIPAL REGISTER |
| 17th Dec 2020 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 17th Dec 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 28th Oct 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 26th Oct 2020 | NOTICE OF ALLOWANCE CANCELLED |
| 26th Oct 2020 | TEAS DELETE 1(B) BASIS RECEIVED |
| 26th Oct 2020 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 07th Jul 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th May 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th May 2020 | PUBLISHED FOR OPPOSITION |
